Price Alert

Sensus Healthcare Inc. (SRTS)

NASDAQ: SRTS · Real-Time Price · USD

3.44

0.02 (0.58%)

At close: Aug 14, 2025, 3:59 PM

3.44

0.00%

After-hours: Aug 14, 2025, 06:47 PM EDT

0.58% (1D)

Bid	3.3
Market Cap	56.57M
Revenue (ttm)	39.49M
Net Income (ttm)	1.8M
EPS (ttm)	-0.05
PE Ratio (ttm)	-68.8
Forward PE	7.23
Analyst	Buy

Ask	3.44
Volume	116,229
Avg. Volume (20D)	129,470
Open	3.40
Previous Close	3.42
Day's Range	3.30 - 3.44
52-Week Range	3.03 - 9.33
Beta	1.35

About SRTS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SRTS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SRTS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Sensus Healthcare has released their quartely earnings on Aug 7, 2025:

Revenue of $7.32M misses estimates by $1.79M, with -20.82% YoY decline.

EPS of -0.06 misses estimates by -0.07, with -160.00% YoY decline.

Next Earnings Release

Sensus Healthcare Inc. is scheduled to release its earnings on Nov 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+0.38%

Sensus Healthcare shares are trading lower after t... Unlock content with Pro Subscription

6 months ago

-32.37%

Sensus Healthcare shares are trading lower after the company reported mixed Q4 financial results.

News

1 week ago · seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Javier Rampolla - Chief Financial Officer Joseph C. Sardano - Co-Founder, Chairma...

1 week ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Sensus Healthcare, Inc. (SRTS) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.01. This compares to earnings of $0.1 per share a year ago.

1 week ago · fool.com

Sensus (SRTS) Q2 Revenue Falls 21%

3 weeks ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note

In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day.

3 weeks ago · businesswire.com

Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for...

4 weeks ago · zacks.com

Why Sensus Healthcare, Inc. (SRTS) Outpaced the Stock Market Today

Sensus Healthcare, Inc. (SRTS) reached $4.44 at the closing of the latest trading day, reflecting a +2.54% change compared to its last close.

1 month ago · zacks.com

Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors

Sensus Healthcare, Inc. (SRTS) closed at $4.64 in the latest trading session, marking a -2.11% move from the prior day.

1 month ago · businesswire.com

Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists

BOCA RATON, Fla.--(BUSINESS WIRE)---- $SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS) (Sensus or the Company), a medical device company specializing in highly effective, non-invasive, minimally-invasive...

2 months ago · zacks.com

Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

3 months ago · seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q1 2025 Earnings Call Transcript

Sensus Healthcare, Inc. (NASDAQ:SRTS ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, IR Joe Sardano - Chairman and CEO Michael Sardano ...

Load More News